Biofrontera Inc reports results for the quarter ended in June - Earnings Summary

Biofrontera

16/08/2024 05:53

* Biofrontera Inc  BFRI.OQ  reported a quarterly adjusted
loss
of 5 cents​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of $-7.23.  The mean expectation of two analysts for the quarter
was for a loss of 77 cents per share. Wall Street expected
results to range from $-1.19 to -35 cents per share.
    * Revenue rose 34% to $7.84 million from a year ago;
analysts
expected $8.21 million. 
    * Biofrontera Inc's reported EPS for the quarter was a loss
of 5
cents​.
    * The company reported a quarterly loss of $257 thousand.
    * Biofrontera Inc shares had risen by 26.9% this quarter and
lost 58.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 27% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Biofrontera Inc
is $11.50 
This summary was machine generated from LSEG data August 16 at
04:53 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.77          -0.05          Beat
 Mar. 31 2024      -1.17          -2.88          Missed
 Dec. 31 2023      -1.19          -1.80          Missed
 Sep. 30 2023      -3.78          -4.64          Missed